179626-84-7Relevant articles and documents
BRADYKININ RECEPTOR AGONISTS AND USES THEREOF TO TREAT OCULAR HYPERTENSION AND GLAUCOMA
-
Page/Page column 37, (2012/03/10)
The invention provides compositions and methods for treating and/or preventing ocular disorders associated with increased intraocular pressure. In particular, the compounds are bradykinin agonists.
Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks
Sawada, Yuki,Kayakiri, Hiroshi,Abe, Yoshito,Mizutani, Tsuyoshi,Inamura, Noriaki,Asano, Masayuki,Hatori, Chie,Aramori, Ichiro,Oku, Teruo,Tanaka, Hirokazu
, p. 2853 - 2863 (2007/10/03)
In the course of our studies on non-peptide bradykinin (BK) B2 receptor ligands, it was suggested that the 4-substituent of the quinoline ring may play a critical role in determining binding affinities for human and guinea pig B2 rec
Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists
-
, (2008/06/13)
This invention relates to a compound of the formula: STR1 wherein Z is a group of the formula: STR2 in which X1 is N or C--R1, X2 is N or C--R9, X3 is N or C--R2, R1 is lower alk